Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
243 studies found for:    Open Studies | "Colitis"
Show Display Options
Rank Status Study
21 Recruiting Linked Color Imaging vs. White Light for Colorectal Dysplasia in Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Linked Color Imaging;   Device: white light imaging
22 Recruiting Interest of Propionibacterium Freudenreichii for the Treatment of Mild to Moderate Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Other: Probiotics in the form of cheese portion
23 Not yet recruiting Ulcerative Colitis Relapse Prevention by Prebiotics
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Synergy-1;   Dietary Supplement: Maltodextrin
24 Not yet recruiting Development of a Biomarker of Efficacy of Vedolizumab (EnTyvio®) in Patients With ulcErative ColiTis (DETECT)
Condition: ULCERATIVE COLITIS
Interventions: Drug: VEDOLIZUMAB;   Drug: ADALIMUMAB
25 Recruiting Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
26 Recruiting Comparison of PillCamCOLON (C2) Capsule and Standard Endoscopy for the Evaluation of Patients With Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: standard endoscopy;   Device: PillCamCOLON (C2)
27 Recruiting Thermography in Surveillance of Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Device: Thermography;   Procedure: Colonoscopy
28 Not yet recruiting A Randomized, Multicenter Open Label Study Comparing Early Administration of Azathioprine Plus IFX to Steroids Plus Azathioprine for Acute Severe Colitis
Condition: Ulcerative Colitis
Interventions: Drug: Azathioprine;   Drug: Infliximab;   Drug: Prednisolone;   Drug: Hydrocortisone
29 Recruiting Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea
Condition: Colitis, Ulcerative
Intervention: Other: No Intervention
30 Not yet recruiting An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
31 Recruiting Low Dose IL-2 for Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: Interleukin-2 (aldesleukin).
32 Recruiting FMT in Ulcerative Colitis-Associated Pouchitis
Condition: Ulcerative Colitis Associated Pouchitis
Interventions: Biological: biologically active human fecal microbiota;   Procedure: sigmoidoscopy
33 Recruiting Human Umbilical-Cord-Derived Mesenchymal Stem Cell Therapy in Active Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Biological: UCMSC group;   Other: Control group(Normal saline)
34 Not yet recruiting The Role of CD4+ T Cell Subsets in the Mechanism of Action of Vedolizumab in Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention:
35 Recruiting A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Intervention:
36 Recruiting A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC)
Condition: Ulcerative Colitis
Interventions: Drug: LT-02;   Drug: LT-02 Placebo
37 Recruiting Mind-Body Medicine and Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Behavioral: Mind/Body Medicine Course 1;   Behavioral: Mind/Body Medicine Course 2
38 Recruiting Budesonide for Induction of Remission in Incomplete Microscopic Colitis
Condition: Incomplete Microscopic Colitis
Interventions: Drug: Budesonide granules 9 mg;   Drug: Placebo granules
39 Not yet recruiting Curcumin in Pediatric Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Dietary Supplement: Curcumin;   Drug: Placebo
40 Recruiting GSK2982772 Study in Ulcerative Colitis Patients
Condition: Colitis, Ulcerative
Interventions: Drug: GSK2982772;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.